Document Detail


Reduction of lysosomal storage in murine mucopolysaccharidosis type VII by transplantation of normal and genetically modified macrophages.
MedLine Citation:
PMID:  10828055     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study examined the ability of macrophages to serve as target cells of gene therapy for mucopolysaccharidosis (MPS) type VII using a murine model. Bone marrow cells were harvested from syngeneic normal mice and differentiated to macrophages. These cells were given to nonmyeloablated MPS VII mice. After transplantation, donor cells populated the liver and spleen. The pathologic improvement at day 38 after transplantation was significant and glycosaminoglycan storage was reduced. To develop gene therapy using this system, a retroviral vector expressing human beta-glucuronidase (HBG) was used to infect macrophages cultivated from MPS VII mice and given to nonmyeloablated MPS VII mice. At 38 days after transplantation, HBG-positive cells were still observed histochemically and pathologic improvement was significant. These observations suggest that macrophage transplantation is a promising method for treatment of murine MPS VII without myeloablation, and macrophages may be good target cells for ex vivo gene therapy for MPS VII.
Authors:
T Ohashi; T Yokoo; S Iizuka; H Kobayashi; W S Sly; Y Eto
Related Documents :
8831605 - Efficacy and safety of repeated hepatocyte transplantation for significant liver repopu...
12100615 - Temporary amelioration of bilirubin conjugation defect in gunn rats by transplanting co...
22747475 - Significance of c4d deposition in antibody-mediated rejection.
22586485 - The prevalence of immunologic injury in renal allograft recipients with de novo protein...
19543065 - Donor risk index and meld interactions in predicting long-term graft survival: a single...
23110425 - Histologic and biomechanical studies of tendon-to-bone healing after autologous and all...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Blood     Volume:  95     ISSN:  0006-4971     ISO Abbreviation:  Blood     Publication Date:  2000 Jun 
Date Detail:
Created Date:  2000-06-29     Completed Date:  2000-06-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7603509     Medline TA:  Blood     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  3631-3     Citation Subset:  AIM; IM    
Affiliation:
Department of Gene Therapy, Institute of DNA Medicine, Jikei University School of Medicine, Tokyo, Japan. tohashi@gd5.so-net.ne.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Bone Marrow Cells / cytology*
Cell Differentiation
Disease Models, Animal
Gene Therapy*
Glucuronidase / biosynthesis,  deficiency,  genetics*
Humans
Kupffer Cells / pathology,  ultrastructure
Lysosomes / pathology,  ultrastructure*
Macrophages / cytology,  transplantation*
Mice
Mice, Inbred Strains
Mice, Knockout
Mucopolysaccharidosis VII / therapy*
Recombinant Proteins / biosynthesis
Transfection
Transplantation, Isogeneic
Chemical
Reg. No./Substance:
0/Recombinant Proteins; EC 3.2.1.31/Glucuronidase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extran...
Next Document:  Structural insights into the protein splicing mechanism of PI-SceI.